Blood Preparation Market Size To Reach $91.88 Billion By 2033

March 2026 | Report Format: Electronic (PDF)

Blood Preparation Market Growth & Trends

The global blood preparation market size is estimated to reach USD 91.88 billion by 2033, registering a CAGR of 7.1% from 2026 to 2033, according to a new report by Grand View Research, Inc. The key factors driving the market include growing prevalence of blood-related disorders, extensive usage of its components in several surgical procedures, rising number of transfusion procedures.

Rising number of injuries & accidents, increasing blood donations, and growing government initiatives to raise awareness regarding donation are expected to propel the market during the forecast period. For instance, in November 2022, the World Health Organization/ Pan American Health Organization (PAHO/WHO) with funding support from the United States of America conducted an awareness program by donating promotional items for voluntary donation to save lives in Belize . Moreover, the increasing usage of plasma as life-saving therapeutics for numerous chronic and acute life-threatening diseases such as Hemophilia and Hereditary Angioedema in the biopharmaceutical and pharmaceutical industries is likely to boost the blood preparation market.

The operating players in the market are undertaking numerous strategies such as collaborations, mergers & acquisitions, and product launches. Furthermore, the companies are also focusing on extending their investments on expansion of manufacturing facilities with an aim to meet the demand. For instance, in May 2023, PlasmaGen Biosciences announced an opening of its new facility to boost the production of blood plasma products in India . The facility aims to significantly enhance the supply-demand scenario for products at reasonable prices.

However, the growing incidence of allergic reactions through the transfusion including hypotensive transfusion reactions are anticipated to hamper the market in the study period. In addition, high changes of disease transmission during transfusions such as hepatitis B, HIV and viral hemorrhagic fever may impede the market.

On the other hand, innovations in collection and processing technologies such as automated collection systems, can improve the quality of products by reducing the processing time. For instance, in May 2022, Vitestro, introduced an innovative autonomous blood drawing device. The device is combination of ultrasound-guided 3D reconstruction and artificial intelligence (AI) with robotic needle insertion for secure and precise collection . Thus such initiatives are projected to create lucrative opportunities during the forecast period.

key Request a free sample copy or view report summary: Blood Preparation Market Report

Blood Preparation Market Report Highlights

Based on product, the whole blood product segment held the largest revenue share at 45.51% in 2025, attributed to an increasing demand for major surgeries and transfusions along with its advantages, such as easy availability, low cost, and maintenance.
Based on antithrombotic and anticoagulants, the anticoagulants segment held the largest revenue share at 65.00% in 2025, attributed to the introduction of new products and the increasing prevalence of cardiac conditions.
Based on application, the thrombocytosis segment captured the largest revenue share at 21.40% in 2025, driven by growing awareness and diagnosis of the condition, and advancements in diagnostic techniques.
North America blood preparation market dominated and accounted for a 43.71% share in 2025, owing to the high incidence of CVDs, leukemia, and hematological and neurological diseases in the region.

Blood Preparation Market Segmentation

Grand View Research has segmented the global blood preparation market based on product, antithrombotic & anticoagulants, application, and region:

Blood Preparation Product Outlook (Revenue, USD Million, 2021 - 2033)

Whole Blood
- Red Cells
- Granulocytes
- Plasma
- Platelets
Blood Components
- Whole Blood Components
- Packed Red Cells
- Leukocyte Reduced Red Blood Cells
- Frozen Plasma
- Platelet Concentrate
- Cryoprecipitate
Blood Derivatives

Blood Preparation Antithrombotic and Anticoagulants Outlook (Revenue, USD Million, 2021 - 2033)

Platelet Aggregation Inhibitors
- Glycoprotein Inhibitors
- COX Inhibitors
- ADP Antagonists
- Others
Fibrinolytics
- Tissue Plasminogen Activator (tPA)
- Streptokinase
- Urokinase
Anticoagulants
- Heparins
  - Unfractionated Heparin
  - Low Molecular Weight Heparin (LMWH)
  - Ultra-low Molecular Weight Heparin
- Vitamin K Antagonists
- Direct Thrombin Inhibitors
- Direct Factor Xa Inhibitors